Etretinate
Etretinate is a RAR and RXR agonist previoulsy used to treat psoriasis. It induces brth defects and suppresses proliferation in cutaneous T-cell lymphoma models.
Product Specifications
CAS Number
54350-48-0
Product Name Alternative
Ethyl etrinoate | HSDB 7185 | HSDB7185 | Ro 10-9359
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 25 mg/mL (70.53 mM)
Smiles
CCOC (=O) /C=C (\C) /C=C/C=C (\C) /C=C/C1=C (C (=C (C=C1C) OC) C) C
Molecular Formula
C23H30O3
Molecular Weight
354.48
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Ethyl (2E,4E,6E,8E) -9- (4-methoxy-2,3,6-trimethylphenyl) -3,7-dimethylnona-2,4,6,8-tetraenoate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx117046 100 µL
B-Cell CLL/Lymphoma 2 Like Protein 2 (BCL2L2) Antibody
Sign In for Pricing
View Details 
MBS1279546-01 0.02 mg (E-Coli)
Recombinant Alcanivorax borkumensis Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details MBS1279546-02 0.1 mg (E-Coli)
Recombinant Alcanivorax borkumensis Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details MBS1279546-03 0.02 mg (Yeast)
Recombinant Alcanivorax borkumensis Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details MBS1279546-04 0.1 mg (Yeast)
Recombinant Alcanivorax borkumensis Nucleoside diphosphate kinase (ndk)
Sign In for Pricing
View Details